Deborah K. Morrison
Research Subjects
Deborah K. Morrison has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Daniel A. Ritt
Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, P. O. Box B, Frederick, MD 21702
5 shared publicationsMing Zhou
3 shared publicationsTerry D. Copeland
3 shared publicationsTimothy D. Veenstra
3 shared publications- Jürgen Müller
Warwick Medical School, University of Warwick, Coventry, UK
2 shared publications Melissa M. McKay
Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA
2 shared publications
Latest Publications
- 16 July 2010
- Published by Springer Nature
- Vol. 661, 323-334
Proteomic Analysis of Scaffold Proteins in the ERK Cascade
ERK cascade scaffolds serve as docking platforms to coordinate the assembly of multiprotein complexes that contribute to the spatial and temporal control of ERK signaling. Given that protein–protein interactions are essential for scaffold function, determining the full repertoire of scaffold binding partners will likely provide new insight into the regulation and activities of the ERK cascade scaffolds. In this chapter, we describe methods to identify scaffold interacting proteins using a proteomics approach. This protocol is based on the affinity purification of scaffold complexes from tissue culture cells and utilizes mass spectrometry to identify the protein constituents of the complex.
- 16 July 2010
- Published by Springer Nature
- Vol. 661, 323-334
Proteomic Analysis of Scaffold Proteins in the ERK Cascade
ERK cascade scaffolds serve as docking platforms to coordinate the assembly of multiprotein complexes that contribute to the spatial and temporal control of ERK signaling. Given that protein–protein interactions are essential for scaffold function, determining the full repertoire of scaffold binding partners will likely provide new insight into the regulation and activities of the ERK cascade scaffolds. In this chapter, we describe methods to identify scaffold interacting proteins using a proteomics approach. This protocol is based on the affinity purification of scaffold complexes from tissue culture cells and utilizes mass spectrometry to identify the protein constituents of the complex.
- 7 July 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (27) , 11022-11027
Signaling dynamics of the KSR1 scaffold complex
Scaffold proteins contribute to the spatiotemporal control of MAPK signaling and KSR1 is an ERK cascade scaffold that localizes to the plasma membrane in response to growth factor treatment. To better understand the molecular mechanisms of KSR1 function, we examined the interaction of KSR1 with each of the ERK cascade components, Raf, MEK, and ERK. Here, we identify a hydrophobic motif within the proline-rich sequence (PRS) of MEK1 and MEK2 that is required for constitutive binding to KSR1 and find that MEK binding and residues in the KSR1 CA1 region enable KSR1 to form a ternary complex with B-Raf and MEK following growth factor treatment that enhances MEK activation. We also find that docking of active ERK to the KSR1 scaffold allows ERK to phosphorylate KSR1 and B-Raf on feedback S/TP sites. Strikingly, feedback phosphorylation of KSR1 and B-Raf promote their dissociation and result in the release of KSR1 from the plasma membrane. Together, these findings provide unique insight into the signaling dynamics of the KSR1 scaffold and reveal that through regulated interactions with Raf and ERK, KSR1 acts to both potentiate and attenuate ERK cascade activation, thus regulating the intensity and duration of ERK cascade signaling emanating from the plasma membrane during growth factor signaling.
- 7 July 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (27) , 11022-11027
Signaling dynamics of the KSR1 scaffold complex
Scaffold proteins contribute to the spatiotemporal control of MAPK signaling and KSR1 is an ERK cascade scaffold that localizes to the plasma membrane in response to growth factor treatment. To better understand the molecular mechanisms of KSR1 function, we examined the interaction of KSR1 with each of the ERK cascade components, Raf, MEK, and ERK. Here, we identify a hydrophobic motif within the proline-rich sequence (PRS) of MEK1 and MEK2 that is required for constitutive binding to KSR1 and find that MEK binding and residues in the KSR1 CA1 region enable KSR1 to form a ternary complex with B-Raf and MEK following growth factor treatment that enhances MEK activation. We also find that docking of active ERK to the KSR1 scaffold allows ERK to phosphorylate KSR1 and B-Raf on feedback S/TP sites. Strikingly, feedback phosphorylation of KSR1 and B-Raf promote their dissociation and result in the release of KSR1 from the plasma membrane. Together, these findings provide unique insight into the signaling dynamics of the KSR1 scaffold and reveal that through regulated interactions with Raf and ERK, KSR1 acts to both potentiate and attenuate ERK cascade activation, thus regulating the intensity and duration of ERK cascade signaling emanating from the plasma membrane during growth factor signaling.
- 1 June 2009
- Published by Elsevier in Molecular Cell
- Vol. 34 (6) , 652-662
KSR2 Is a Calcineurin Substrate that Promotes ERK Cascade Activation in Response to Calcium Signals
- 1 June 2009
- Published by Elsevier in Molecular Cell
- Vol. 34 (6) , 652-662
KSR2 Is a Calcineurin Substrate that Promotes ERK Cascade Activation in Response to Calcium Signals
- 1 January 2009
- Published by Elsevier in Trends in Cell Biology
- Vol. 19 (1) , 16-23
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
- 1 January 2009
- Published by Elsevier in Trends in Cell Biology
- Vol. 19 (1) , 16-23
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
- 14 May 2007
- Published by Springer Nature in Oncogene
- Vol. 26 (22) , 3113-3121
Integrating signals from RTKs to ERK/MAPK
Signals received at the cell surface must be properly transmitted to critical targets within the cell to achieve the appropriate biological response. This process of signal transduction is often initiated by receptor tyrosine kinases (RTKs), which function as entry points for many extracellular cues and play a critical role in recruiting the intracellular signaling cascades that orchestrate a particular response. Essential for most RTK-mediated signaling is the engagement and activation of the mitogen-activated protein kinase (MAPK) cascade comprised of the Raf, MEK and extracellular signal-regulated kinase (ERK) kinases. For many years, it was thought that signaling from RTKs to ERK occurred only at the plasma membrane and was mediated by a simple, linear Ras-dependent pathway. However, the limitation of this model became apparent with the discovery that Ras and ERK can be activated at various intracellular compartments, and that RTKs can modulate Ras/ERK signaling from these sites. Moreover, ERK scaffolding proteins and signaling modulators have been identified that play critical roles in determining the strength, duration and location of RTK-mediated ERK signaling. Together, these factors contribute to the diversity of biological responses generated by RTK signaling.
- 14 May 2007
- Published by Springer Nature in Oncogene
- Vol. 26 (22) , 3113-3121
Integrating signals from RTKs to ERK/MAPK
Signals received at the cell surface must be properly transmitted to critical targets within the cell to achieve the appropriate biological response. This process of signal transduction is often initiated by receptor tyrosine kinases (RTKs), which function as entry points for many extracellular cues and play a critical role in recruiting the intracellular signaling cascades that orchestrate a particular response. Essential for most RTK-mediated signaling is the engagement and activation of the mitogen-activated protein kinase (MAPK) cascade comprised of the Raf, MEK and extracellular signal-regulated kinase (ERK) kinases. For many years, it was thought that signaling from RTKs to ERK occurred only at the plasma membrane and was mediated by a simple, linear Ras-dependent pathway. However, the limitation of this model became apparent with the discovery that Ras and ERK can be activated at various intracellular compartments, and that RTKs can modulate Ras/ERK signaling from these sites. Moreover, ERK scaffolding proteins and signaling modulators have been identified that play critical roles in determining the strength, duration and location of RTK-mediated ERK signaling. Together, these factors contribute to the diversity of biological responses generated by RTK signaling.
- 1 January 2007
- Published by Elsevier in Current Biology
- Vol. 17 (2) , 179-184
CK2 Is a Component of the KSR1 Scaffold Complex that Contributes to Raf Kinase Activation
- 1 January 2007
- Published by Elsevier in Current Biology
- Vol. 17 (2) , 179-184
CK2 Is a Component of the KSR1 Scaffold Complex that Contributes to Raf Kinase Activation
- 1 January 2005
- Published by Elsevier in Molecular Cell
- Vol. 17 (2) , 215-224
Regulation of Raf-1 by Direct Feedback Phosphorylation
- 1 January 2005
- Published by Elsevier in Molecular Cell
- Vol. 17 (2) , 215-224
Regulation of Raf-1 by Direct Feedback Phosphorylation
- Open Access
- 1 April 2004
- Published by Springer Nature in Nature
- Vol. 428 (6985) , 813-815
Enzymes play molecular tag
- 1 April 2004
- Published by Springer Nature in Nature
- Vol. 428 (6985) , 813-815
Open AccessEnzymes play molecular tag
- 1 November 2003
- Published by Annual Reviews in Annual Review of Cell and Developmental Biology
- Vol. 19 (1) , 91-118
Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals
▪ Abstract The mitogen-activated protein kinase (MAPK) group of serine/threonine protein kinases mediates the response of cells to many extracellular stimuli such as cytokines and growth factors. These protein kinases include the extracellular signal-regulated protein kinases (ERK) and two stress-activated protein kinases (SAPK), the c-Jun N-terminal kinases (JNK), and the p38 MAPK. The enzymes are evolutionarily conserved and are activated by a common mechanism that involves a protein kinase cascade. Scaffold proteins have been proposed to interact with MAPK pathway components to create a functional signaling module and to control the specificity of signal transduction. Here we critically evaluate the evidence that supports a physiologically relevant role of MAPK scaffold proteins in mammals.
- 1 November 2003
- Published by Annual Reviews in Annual Review of Cell and Developmental Biology
- Vol. 19 (1) , 91-118
Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals
▪ Abstract The mitogen-activated protein kinase (MAPK) group of serine/threonine protein kinases mediates the response of cells to many extracellular stimuli such as cytokines and growth factors. These protein kinases include the extracellular signal-regulated protein kinases (ERK) and two stress-activated protein kinases (SAPK), the c-Jun N-terminal kinases (JNK), and the p38 MAPK. The enzymes are evolutionarily conserved and are activated by a common mechanism that involves a protein kinase cascade. Scaffold proteins have been proposed to interact with MAPK pathway components to create a functional signaling module and to control the specificity of signal transduction. Here we critically evaluate the evidence that supports a physiologically relevant role of MAPK scaffold proteins in mammals.
- Open Access
- 1 September 2003
- Published by Springer Nature in The EMBO Journal
- Vol. 22 (17) , 4431-4442
Functional analysis of C‐TAK1 substrate binding and identification of PKP2 as a new C‐TAK1 substrate
Cdc25C‐associated kinase 1 (C‐TAK1) has been implicated in cell cycle regulation and Ras signaling through its interactions with two putative substrates, the Cdc25C phosphatase and the MAPK scaffold KSR1. Here, we identify sequence motifs required for stable C‐TAK1 association and substrate phosphorylation. Using a mutational approach to disrupt binding of C‐TAK1 to KSR1 and Cdc25C, we demonstrate that C‐TAK1 contributes to the regulation of these proteins in vivo through the generation of 14‐3‐3‐binding sites. KSR1 proteins defective in C‐TAK1 binding had severely reduced phosphorylation at the 14‐3‐3‐binding site in vivo , were constitutively localized to the plasma membrane and had increased biological activity. Disruption of the Cdc25C–C‐TAK1 interaction resulted in reduced 14‐3‐3‐binding site phosphorylation and nuclear accumulation of Cdc25C in interphase cells. Finally, utilizing the acquired C‐TAK1 binding and substrate phosphorylation data, we identify plakophilin 2 (PKP2) as a novel C‐TAK1 substrate. Phosphorylation of PKP2 by C‐TAK1 also generates a 14‐3‐3‐binding site that influences PKP2 localization. These findings underscore the importance of C‐TAK1 as a regulator of 14‐3‐3 binding and protein localization.
- 1 September 2003
- Published by Springer Nature in The EMBO Journal
- Vol. 22 (17) , 4431-4442
Open AccessFunctional analysis of C‐TAK1 substrate binding and identification of PKP2 as a new C‐TAK1 substrate
Cdc25C‐associated kinase 1 (C‐TAK1) has been implicated in cell cycle regulation and Ras signaling through its interactions with two putative substrates, the Cdc25C phosphatase and the MAPK scaffold KSR1. Here, we identify sequence motifs required for stable C‐TAK1 association and substrate phosphorylation. Using a mutational approach to disrupt binding of C‐TAK1 to KSR1 and Cdc25C, we demonstrate that C‐TAK1 contributes to the regulation of these proteins in vivo through the generation of 14‐3‐3‐binding sites. KSR1 proteins defective in C‐TAK1 binding had severely reduced phosphorylation at the 14‐3‐3‐binding site in vivo , were constitutively localized to the plasma membrane and had increased biological activity. Disruption of the Cdc25C–C‐TAK1 interaction resulted in reduced 14‐3‐3‐binding site phosphorylation and nuclear accumulation of Cdc25C in interphase cells. Finally, utilizing the acquired C‐TAK1 binding and substrate phosphorylation data, we identify plakophilin 2 (PKP2) as a novel C‐TAK1 substrate. Phosphorylation of PKP2 by C‐TAK1 also generates a 14‐3‐3‐binding site that influences PKP2 localization. These findings underscore the importance of C‐TAK1 as a regulator of 14‐3‐3 binding and protein localization.